Veröffentlichungen zu Hammes, Hans-Peter | ||||||||||||||
Verfasser | Titel | Jahr ![]() ![]() |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() 1 |
Hammes, Hans-Peter, Brownlee, Michael, ... |
Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularization in: Nature medicine . - New York, NY : Nature America Inc., ISSN 1546-170X, Vol. 2, No. 5 (1996), p. 529-533 Zugang: zum Volltext ähnliche Vorschläge |
1996 | |||||||||||
![]() 2 |
Nishikawa, Takeshi, Edelstein, Diane, ... |
Normalizing mitochondrial superoxide production blocks three pathwaysof hyperglycaemic damage in: Nature . - London [u.a.] : Nature Publising Group, ISSN 1476-4687, Vol. 404, No. 6779 (2000), p. 787-790 Zugang: zum Volltext ähnliche Vorschläge |
2000 | |||||||||||
![]() 3 |
Hammes, Hans-Peter, Du, Xueliang, ... |
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy in: Nature medicine . - New York, NY : Nature America Inc., ISSN 1546-170X, Vol. 9, No. 3 (2003), p. 294-299 Zugang: zum Volltext ähnliche Vorschläge |
2003 | |||||||||||
Three of the major biochemical pathways implicated in the pathogenesis of hyperglycemia induced vascular damage (the hexosamine pathway, the advanced glycation end product (AGE) formation pathway and the diacylglycerol (DAG)–protein kinase C (PKC) pathway) are activated by increased... mehr
|